Antisense Making Lots Of Sense To Biotech Researchers

Research Antisense Making Lots Of Sense To Biotech Researchers Author: Joshua Fischman, p. 14, 17. In the early 1980s, at an international conference on synthetic DNA and disease, molecular biologist James Hawkins first heard what chemists proposed to do with small pieces of synthetic genetic material called antisense DNA. And he was stunned. "It was the first time," he says, "that there was a clear concept: `Let's send these molecules into a cell and regulate a gene.' This was apocalyptic--tha

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Research

Antisense Making Lots Of Sense To Biotech Researchers

In the early 1980s, at an international conference on synthetic DNA and disease, molecular biologist James Hawkins first heard what chemists proposed to do with small pieces of synthetic genetic material called antisense DNA. And he was stunned.

"It was the first time," he says, "that there was a clear concept: `Let's send these molecules into a cell and regulate a gene.' This was apocalyptic--that's how profound it was for me." To some people, the concept, while profound, was also somewhat unbelievable. Indeed, Hawkins recalls, if you embraced it fully, "you were seen as a bit of a yahoo at the time, because the basic research wasn't established."

It's not unbelievable anymore. What the researchers were suggesting about antisense DNA at that international conference heralded what many experts now see as the next revolution in drug design. Hawkins is now president ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Joshua Fischman

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo